The Ser680Asn polymorphism in the follicle-stimulating hormone receptor gene is associated with the ovarian response in controlled ovarian hyperstimulation

Clinical Endocrinology

Volumn 82, Issue 4, 2015, Pages 577-583

  Huang, Xianliang ^a,b   Li, Lu ^c   Hong, Ling ^d   Zhou, Weijin ^b   Shi, Huijuan ^b   Zhang, Huiqin ^b   Zhang, Zhaofeng ^b   Sun, Xiaoxi ^c,e   Du, Jing ^b  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI INSTITUTE OF PLANNED PARENTHOOD RESEARCH   (China)

^c GENETICS AND IVF INSTITUTE   (United States)

^d TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^e OBSTETRICS AND GYNECOLOGY HOSPITAL OF FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; FOLLITROPIN; GONADOTROPIN; ASPARAGINE; FOLLITROPIN RECEPTOR; SERINE;

ADULT; ARTICLE; CHEMOLUMINESCENCE; FEMALE; GENOTYPE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; OOCYTE; OVARY FOLLICLE FLUID; OVARY HYPERSTIMULATION; PRIORITY JOURNAL; RECEPTOR GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE; ALLELE; BLOOD; BODY MASS; CHINA; COHORT ANALYSIS; CYTOLOGY; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETICS; HOMOZYGOTE; INTRACYTOPLASMIC SPERM INJECTION; MASS SPECTROMETRY; METABOLISM; OVARY; OVULATION INDUCTION; PHYSIOLOGY; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; ALLELES; ASPARAGINE; BODY MASS INDEX; CHINA; COHORT STUDIES; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; GENOTYPE; GONADOTROPINS; HOMOZYGOTE; HUMANS; INFERTILITY, FEMALE; LINKAGE DISEQUILIBRIUM; OOCYTES; OVARIAN HYPERSTIMULATION SYNDROME; OVARY; OVULATION INDUCTION; POLYMORPHISM, GENETIC; RECEPTORS, FSH; SERINE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SPERM INJECTIONS, INTRACYTOPLASMIC; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84924049245     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12573     Document Type: Article

References (34)

1. Strickler, R.C., Radwanska, E., &, Williams, D.B., (1995) Controlled ovarian hyperstimulation regimens in assisted reproductive technologies. American Journal of Obstetrics and Gynecology, 172 (2 Pt 2), 766-773.
2. de Castro, F., Moron, F.J., Montoro, L., et al,. (2005) Pharmacogenetics of controlled ovarian hyperstimulation. Pharmacogenomics, 6, 629-637.
3. Broekmans, F.J., Kwee, J., Hendriks, D.J., et al,. (2006) A systematic review of tests predicting ovarian reserve and IVF outcome. Human Reproduction Update, 12, 685-718.
4. Olivennes, F., Howies, C.M., Borini, A., et al,. (2011) Individualizing FSH dose for assisted reproduction using a novel algorithm: the CONSORT study. Reproductive Biomedicine Online, 22 (Suppl 1), S73-S82.
5. Kligman, I., &, Rosenwaks, Z., (2001) Differentiating clinical profiles: predicting good responders, poor responders, and hyperresponders. Fertility and Sterility, 76, 1185-1190.
6. Nelson, S.M., (2013) Biomarkers of ovarian response: current and future applications. Fertility and Sterility, 99, 963-969.
7. Altmae, S., Hovatta, O., Stavreus-Evers, A., et al,. (2011) Genetic predictors of controlled ovarian hyperstimulation: where do we stand today? Human Reproduction Update, 17, 813-828.
8. Loutradis, D., Vlismas, A., Drakakis, P., et al,. (2008) Pharmacogenetics in ovarian stimulation-current concepts. Annals of the New York Academy of Sciences, 1127, 10-19.
9. Ulloa-Aguirre, A., Zarinan, T., Pasapera, A.M., et al,. (2007) Multiple facets of follicle-stimulating hormone receptor function. Endocrine, 32, 251-263.
10. Casarini, L., Pignatti, E., &, Simoni, M., (2011) Effects of polymorphisms in gonadotropin and gonadotropin receptor genes on reproductive function. Reviews in Endocrine & Metabolic Disorders, 12, 303-321.
11. Simoni, M., Tempfer, C.B., Destenaves, B., et al,. (2008) Functional genetic polymorphisms and female reproductive disorders: part I: polycystic ovary syndrome and ovarian response. Human Reproduction Update, 14, 459-484.
12. Simoni, M., &, Casarini L., (2014) Mechanisms in endocrinology: genetics of FSH action a 2014-and-betond view. European Journal of Endocrinology, 170, R91-R107.
13. Perez, M.M., Gromoll, J., Behre, H.M., et al,. (2000) Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. Journal of Clinical Endocrinology and Metabolism, 85, 3365-3369.
14. Sudo, S., Kudo, M., Wada, S., et al,. (2002) Genetic and functional analyses of polymorphisms in the human FSH receptor gene. Molecular Human Reproduction, 8, 893-899.
15. Yao, Y., Ma, C.H., Tang, H.L., et al,. (2011) Influence of follicle-stimulating hormone receptor (FSHR) Ser680Asn polymorphism on ovarian function and in-vitro fertilization outcome: a meta-analysis. Molecular Genetics and Metabolism, 103, 388-393.
16. Mohiyiddeen, L., Newman, W.G., Cerra, C., et al,. (2013) A common Ser680Asn polymorphism in the follicle-stimulating hormone receptor gene is not associated with ovarian response to gonadotropin stimulation in patients undergoing in vitro fertilization. Fertility and Sterility, 99, 149-155.
17. Mohiyiddeen, L., Newman, W.G., McBurney, H., et al,. (2012) Follicle-stimulating hormone receptor gene polymorphisms are not associated with ovarian reserve markers. Fertility and Sterility, 97, 677-681.
18. Binder, H., Strick, R., Zaherdoust, O., et al,. (2012) Assessment of FSHR variants and antimüllerian hormone in infertility patients with a reduced ovarian response to gonadotropin stimulation. Fertility and Sterility, 97, 1169-1175.
19. Achrekar, S.K., Modi, D.N., Desai, S.K., et al,. (2009) Follicle-stimulatin hormone receptor polymorphism (Thr307Ala) is associated with variable ovarian response and ovarian hyperstimulation syndrome in Indian women. Fertility and Sterility, 91, 432-439.
20. Du, J., Zhang, W., Guo, L., et al,. (2010) Two FSHR variants, haplotypes and meta-analysis in Chinese women with premature ovarian failure and polycystic ovary syndrome. Molecular Genetics and Metabolism, 100, 292-295.
21. Gabriel, S., Ziaugral, L., &, Tabbaa, D., (2009) SNP genotyping using the Sequenom MassARRAY iPLEX platform. Current Protocols in Human Genetics, 60, 1-18, Chapter2 (Unit2.12).
22. Shi, Y.Y., &, He, L., (2005) SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Research, 15, 97-98.
23. Gerasimova, T., Thanasoula, M.N., Zattas, D., et al,. (2010) Identification and in vitro characterization of follicle stimulating hormone (FSH) receptor variants associated with abnormal ovarian response to FSH. Journal of Clinical Endocrinology and Metabolism, 95, 529-536.
24. Overbeek, A., &, Lambalk, N., (2009) Pharmacogenomics of ovulation induction: facilitating decisions on who, when and how to treat. Pharmacogenomics, 10, 1377-1379.
25. Loutradis, D., Theofanakis, C., Anagnostou, E., et al,. (2012) Genetic profile of SNP(s) and ovulation induction. Current Pharmaceutical Biotechnology, 13, 417-425.
26. van Disseldorp, J., Franke, L., Eijkemans, R., et al,. (2011) Genome-wide analysis shows no genomic predictors of ovarian response to stimulation by exogenous FSH for IVF. Reproductive Biomedicine Online, 22, 382-388.
27. de Koning, C.H., Benjamins, T., Harms, P., et al,. (2006) The distribution of FSH receptor isoforms is related to basal FSH levels in subfertile women with normal menstrual cycles. Human Reproduction, 21, 443-446.
28. Behre, H.M., Greb, R.R., Mempel, A., et al,. (2005) Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation. Pharmacogenetics and Genomics, 15, 451-456.
29. Moron, F.J., &, Ruiz, A., (2010) Pharmacogenetics of controlled ovarian hyperstimulation: time to corroborate the clinical utility of FSH receptor genetic markers. Pharmacogenomics, 11, 1613-1618.
30. Fatemi, H.M., Blockeel, C., &, Devroey, P., (2012) Ovarian stimulation: today and tomorrow. Current Pharmaceutical Biotechnology, 13, 392-397.
31. Nordhoff, V., Sonntag, B., von Tils, D., et al,. (2011) Effects of the FSH receptor genen polymorphism p. N680S on cAMP and steroid production in cultured primary human granulosa cells. Reproductive Biomedicine Online, 23, 196-203.
32. Simoni, M., Gromoll, J., Höppner, W., et al,. (1999) Mutational analysis of the receptor in normal and infertile men: identification and characterization of two discrete FSH receptor isoforms. Journal of Clinical Endocrinology and Metabolism, 84, 751-755.
33. Cascorbi, I., Bruhn, O., &, Werk, A.N., (2013) Challenges in pharmacogenetics. European Journal of Clinical Pharmacology, 69 (Suppl 1), 17-23.
34. de Castro, F., Morón, F.J., Montoro, L., et al,. (2004) Human controlled ovarian hyperstimulation outcome is a polygenic trait. Pharmacogenetics, 14, 285-293.